ASLAN PHARMACEUTICALS LIMITED (a company incorporated in the Cayman Islands) [•] American Depositary Shares Representing [•] Ordinary Shares (par value NT$ 10.00 per share) UNDERWRITING AGREEMENTUnderwriting Agreement • June 17th, 2019 • ASLAN Pharmaceuticals LTD • Pharmaceutical preparations • New York
The ADSs are to be issued pursuant to that certain deposit agreement (the “Deposit Agreement”), dated May 8, 2018, by and among the Company, JPMorgan Chase Bank, N.A., as depositary (the “Depositary”), and owners and beneficial owners from time to time of the American Depositary Receipts (“ADRs”) issued by the Depositary and evidencing the ADSs. Each ADS will initially represent the right to receive five Ordinary Shares deposited pursuant to the Deposit Agreement.
